Evidence map›Paper›PMID 42819374›Full record

ArticleJACS Au2026

Conformational Preference Classification of Integrin-Binding Ligands Using Free Energy Perturbation.

Martin Vögele, Rezvan Shahoei, Loukas Petridis, Jing Li, Fu-Yang Lin, Lingle Wang, Timothy A Springer, Jeremie Vendome

Abstract read
In one paragraph

Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Martin VögeleSchrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.
Rezvan ShahoeiSchrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.
Loukas PetridisSchrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.
Jing LiDepartment of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, Massachusetts 02115, United States.
Fu-Yang LinEli Lilly and Company, 15 Necco St, Boston, Massachusetts 02210, United States.
Lingle WangSchrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.ORCID https://orcid.org/0000-0002-8170-6798
Timothy A SpringerProgram in Cellular and Molecular Medicine, Children's Hospital Boston, 300 Longwood Ave, Boston, Massachusetts 02115, United States.
Jeremie VendomeSchrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.ORCID https://orcid.org/0000-0002-2498-1670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrins are crucial cell adhesion receptors and attractive therapeutic targets, but developing safe small-molecule inhibitors has been challenging, at least in part due to inadvertent partial agonism caused by stabilization of the integrin's open, high-affinity state. To address this challenge, we present a computational approach using Absolute Binding Free Energy Perturbation (AB-FEP) calculations to predict whether a ligand will stabilize the open or closed integrin states, leveraging the difference between the ligand's binding free energy to the respective end states. Despite challenges posed by Ca and Mg ions, metal-coordinating residues in the binding pocket, and the subtlety of structural differences between states, AB-FEP achieved excellent classification performance on a set of known opening and closing ligands, significantly outperforming docking scores and MM-GBSA results. We also showed a good correlation between AB-FEP binding free energy differences and experimental values. Furthermore, AB-FEP provided insights into intermediate integrin states and analysis of simulation trajectories confirmed the formation of a water-mediated hydrogen bond network with an ion in the binding pocket to be characteristic for closing ligands. This work demonstrates AB-FEP as a robust method for classifying integrin ligands by the conformation they stabilize and for understanding their functional mechanisms, offering valuable guidance for designing safe and conformationally selective integrin therapeutics.

Indexed as

absolute binding free energy perturbationcomputer-aided drug designconformational changeFEP+functional selectivityintegrinligandsstructure-based drug discovery

Identifiers

PMID42819374
PMCPMC13625726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.